Effect of montelukast on polymorphonuclear leukocyte functions in asthmatic patientsGÜRER, Ümran Soyogul; BÜYÜKÖZTÜRK, Suna; PALANDÜZ, Sükrü et al.International immunopharmacology. 2003, Vol 3, Num 9, pp 1257-1260, issn 1567-5769, 4 p.Article

Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in childrenDE BENEDICTIS, F. M; DEL GIUDICE, M. M; FORENZA, N et al.The European respiratory journal. 2006, Vol 28, Num 2, pp 291-295, issn 0903-1936, 5 p.Article

A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challengeSTORMS, William; CHERVINSKY, Paul; GHANNAM, Asma F et al.Respiratory medicine. 2004, Vol 98, Num 11, pp 1051-1062, issn 0954-6111, 12 p.Article

Short-term effects of montelukast in stable patients with moderate to severe COPDCELIK, Pinar; SAKAR, Aysin; HAVLUCU, Yavuz et al.Respiratory medicine. 2005, Vol 99, Num 4, pp 444-450, issn 0954-6111, 7 p.Article

Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.KPRICE, D. B; BEN-JOSEPH, R. H; ZHANG, Q et al.Respiratory medicine. 2001, Vol 95, Num 1, pp 83-89, issn 0954-6111Article

Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukastHANI, N; HARTMANN, K; CASPER, C et al.Acta dermato-venereologica. 2000, Vol 80, Num 3, issn 0001-5555, p. 229Article

Correlation of airway obstruction and patient-reported endpoints in clinical studiesSHINGO, S; ZHANG, J; REISS, T. F et al.The European respiratory journal. 2001, Vol 17, Num 2, pp 220-224, issn 0903-1936Article

Add-on montelukast vs double-dose budesonide in nonasthmatic eosinophilic bronchitis: A pilot studyCHUANGCAI; HE, Mu-Zhi; ZHONG, Shu-Qing et al.Respiratory medicine. 2012, Vol 106, Num 10, pp 1369-1375, issn 0954-6111, 7 p.Article

PROTECTIVE EFFECT OF MONTELUKAST AGAINST QUINOLINIC ACID/MALONIC ACID INDUCED NEUROTOXICITY: POSSIBLE BEHAVIORAL, BIOCHEMICAL, MITOCHONDRIAL AND TUMOR NECROSIS FACTOR-α LEVEL ALTERATIONS IN RATSKALONIA, H; KUMAR, P; KUMAR, A et al.Neuroscience. 2010, Vol 171, Num 1, pp 284-299, issn 0306-4522, 16 p.Article

Rate of Suicide in Patients Taking MontelukastJICK, Hershel; WILCOX HAGBERG, Katrina; EGGER, Pascal et al.Pharmacotherapy. 2009, Vol 29, Num 2, pp 165-166, issn 0277-0008, 2 p.Article

Montelukast does not protect against hyperoxia-induced inhibition of alveolarization in newborn ratsJOUVENCEL, Philippe; FAYON, Michael; CHOUKROUN, Marie-Luce et al.Pediatric pulmonology. 2003, Vol 35, Num 6, pp 446-451, issn 8755-6863, 6 p.Article

Effects of oral montelukast on airway function in acute asthmaCYLLY, A; KARA, A; ÖZDEMIR, T et al.Respiratory medicine. 2003, Vol 97, Num 5, pp 533-536, issn 0954-6111, 4 p.Article

Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment periodVAN ADELSBERG, J; PHILIP, G; PEDINOFF, A. J et al.Allergy (Copenhagen). 2003, Vol 58, Num 12, pp 1268-1276, issn 0105-4538, 9 p.Article

Add-on montelukast in antihistamine-resistant chronic idiopathic urticariaKOSNIK, Mitja; SUBIC, Tjasa.Respiratory medicine. 2011, Vol 105, issn 0954-6111, S84-S88, SUP1Article

Chemistry and structure-activity relationships of leukotriene receptor antagonists. DiscussionBERNSTEIN, P. R; DRAZEN; DAHLEN et al.American journal of respiratory and critical care medicine. 1998, Vol 157, Num 6, pp S220-S226, issn 1073-449X, 2Article

Malabsorption Syndrome and Leukotriene InhibitorCHINNAKKANNAN SELVA KUMAR; RASHMI RANJAN DAS; BALAKRISHNAN, C. D et al.Journal of tropical pediatrics (1980). 2011, Vol 57, Num 2, pp 135-137, issn 0142-6338, 3 p.Article

Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukastKLOTSMAN, Michael; YORK, Timothy P; PILLAI, Sreekumar G et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 3, pp 189-196, issn 1744-6872, 8 p.Article

The national montelukast surveyBARNES, Neil; THOMAS, Mike; PRICE, David et al.Journal of allergy and clinical immunology. 2005, Vol 115, Num 1, pp 47-54, issn 0091-6749, 8 p.Article

Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophiliaFRIESEN, Craig A; KEARNS, Gregory L; ANDRE, Linda et al.Journal of pediatric gastroenterology and nutrition. 2004, Vol 38, Num 3, pp 343-351, issn 0277-2116, 9 p.Article

A semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detectionKITCHEN, Chester J; WANG, Amy Q; MUSSON, Donald G et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 31, Num 4, pp 647-654, issn 0731-7085, 8 p.Article

Montelukast treatment of urticariaMCBAYNE, Tyrone O; SIDDALL, Orita M.The Annals of pharmacotherapy. 2006, Vol 40, Num 5, pp 939-942, issn 1060-0280, 4 p.Article

Response to montelukast among subgroups of children aged 2 to 14 years with asthmaMEYER, Katie A; ARDUINO, Jean Marie; SANTANELLO, Nancy C et al.Journal of allergy and clinical immunology. 2003, Vol 111, Num 4, pp 757-762, issn 0091-6749, 6 p.Article

Place du montelukast dans le traitement de l'asthme persistant léger à modéré = Montelukast in the treatment of mild to moderate persistent asthmaBELLECOSTE, V; DEVOUASSOUX, G; PACHECO, Y et al.Revue des maladies respiratoires. 2011, Vol 28, Num 6, pp 706-729, issn 0761-8425, 24 p.Article

The effect of montelukast on respiratory symptoms and lung function in wheezy infantsPELKONEN, Anna S; MALMSTRÖM, Kristiina; SARNA, Seppo et al.The European respiratory journal. 2013, Vol 41, Num 3, pp 664-670, issn 0903-1936, 7 p.Article

Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthmaJAYARAM, L; DUONG, M; PIZZICHINI, M. M. M et al.The European respiratory journal. 2005, Vol 25, Num 1, pp 41-46, issn 0903-1936, 6 p.Article